Roche

Roche eyes FDA filing after bispecific matches Eylea again
Roche eyes FDA filing after bispecific matches Eylea again
Fierce Biotech
Roche
bispecifics
Regeneron
Eylea
clinical trials
faricimab
wet age-related macular degeneration
Flag link:
Further Studies Show Conflicting Results of Arthritis Drug for Severe COVID-19
Further Studies Show Conflicting Results of Arthritis Drug for Severe COVID-19
BioSpace
COVID-19
arthritis
Actemra
RoActemra
Roche
Flag link:
With patent concerns looming, Roche gets a new priority review on blockbuster IPF drug
With patent concerns looming, Roche gets a new priority review on blockbuster IPF drug
Endpoints
Roche
Esbriet
IPF
FDA
priority review
Flag link:
AZ/Daiichi Sankyo’s Enhertu gets second US cancer indication
AZ/Daiichi Sankyo’s Enhertu gets second US cancer indication
Pharmaforum
AstraZeneca
Daiichi Sankyo
stomach cancer
Enhertu
Roche
Herceptin
Flag link:
10 key clinical trials to watch in the first half of 2021
10 key clinical trials to watch in the first half of 2021
BioPharma Dive
clinical trials
Novavax
AstraZeneca
JNJ
vaccines
COVID-19
Biomarin
Amgen
Merck
Pfizer
Roche
SAGE Therapeutics
Biogen
Vertex Pharmaceuticals
Flag link:
Roche, Sanofi arthritis drugs reduce death rates among sickest COVID-19 patients
Roche, Sanofi arthritis drugs reduce death rates among sickest COVID-19 patients
Reuters
COVID-19
Roche
Actemra
Sanofi
Kevzara
Flag link:
Genentech Launches $1B+ RNA Collaboration with Ribometrix
Genentech Launches $1B+ RNA Collaboration with Ribometrix
Genetic Engineering News
Genentech
Roche
Ribometrix
small molecule drugs
drug discovery
R&D
Flag link:
Roche gets FDA breakthrough therapy status for tiragolumab plus Tecentriq
Roche gets FDA breakthrough therapy status for tiragolumab plus Tecentriq
Pharmaceutical Business Review
Roche
FDA
tiragolumab
Tecentriq
non-small cell lung cancer
breakthrough therapies
Flag link:
Merck, Bristol Myers, AstraZeneca and Roche lose bid to expand PD-1/L1 reach in China
Merck, Bristol Myers, AstraZeneca and Roche lose bid to expand PD-1/L1 reach in China
Fierce Pharma
Merck
Bristol-Myers Squibb
AstraZeneca
Roche
Keytruda
Opdivo
Imfinzi
Tecentriq
China
PD-1 inhibitors
Flag link:
Roche eyes an uncertain market for faricimab
Roche eyes an uncertain market for faricimab
EP Vantage
Roche
faricimab
diabetic macular edema
Regeneron
Eylea
Flag link:
Roche's bispecific matches Regeneron's Eylea in phase 3 trials
Roche's bispecific matches Regeneron's Eylea in phase 3 trials
Fierce Biotech
Roche
faricimab
diabetic macular edema
clinical trials
Regeneron
Eylea
bispecific antibodies
Flag link:
MacroGenics wins FDA approval of breast cancer drug
MacroGenics wins FDA approval of breast cancer drug
BioPharma Dive
Margenza
Macrogenics
FDA
breast cancer
Roche
Herceptin
Flag link:
Roche's MS blockbuster Ocrevus, facing new Novartis competition, scores FDA nod for more-convenient infusion
Roche's MS blockbuster Ocrevus, facing new Novartis competition, scores FDA nod for more-convenient infusion
Fierce Pharma
Roche
Novartis
Kesimpta
Ocrevus
MS
multiple sclerosis
Flag link:
Genentech pays Relay $75M for cancer drug, plans KRAS combo
Genentech pays Relay $75M for cancer drug, plans KRAS combo
Fierce Biotech
Genentech
Relay Therapeutics
Roche
KRAS inhibitors
Flag link:
Roche yields to cancer biosim competition by offering 'relevant' discounts: report
Roche yields to cancer biosim competition by offering 'relevant' discounts: report
Fierce Pharma
Roche
biosimilars
CMS
discounts
buy-and-bill
Flag link:
Roche, Blueprint raise pressure on Lilly with new Gavreto approval
Roche, Blueprint raise pressure on Lilly with new Gavreto approval
Pharmaforum
Roche
Blueprint Medicines
Gavreto
thyroid cancer
Retevmo
Eli Lilly
Flag link:
Swiss start-up Noema raises $59m to develop neurology drugs offloaded by Roche
Swiss start-up Noema raises $59m to develop neurology drugs offloaded by Roche
Pharmaforum
Noema
neurological disorders
Roche
Flag link:
Roche shelved these psychiatry drugs. So its former head of neuro cooked up some new plans — and raised $59M for his startup
Roche shelved these psychiatry drugs. So its former head of neuro cooked up some new plans — and raised $59M for his startup
Endpoints
startups
Neuroscience
psychiatry
Roche
Noema
Flag link:
FDA approves Roche’s Xofluza to prevent flu spreading in families
FDA approves Roche’s Xofluza to prevent flu spreading in families
Pharmaforum
FDA
Xofluza
Roche
Genentech
Flu
Flag link:
The Week Ahead In Biotech: Moderna Vaccine And Roche, Revance, Rhythm, Liquidia FDA Updates
The Week Ahead In Biotech: Moderna Vaccine And Roche, Revance, Rhythm, Liquidia FDA Updates
Yahoo/Benzinga
vaccines
COVID-19
Roche
ReVance
Moderna Therapeutics
FDA
Rhythm Pharmaceuticals
Liquidia
Flag link:

Pages